Figure 4.
Impact of adherence on the effectiveness and cost-effectiveness of F-DNA version 1.1 compared with FOBT. F-DNA version 1.1 became more effective than FOBT when the per-cycle adherence with FOBT fell below 85%, and it cost an incremental $50,000/life-year gained when the per-cycle adherence with FOBT was 31%.